• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Med Lactate Dehydrogenase and Susceptibility to Deterioration of Mild COVID-19 Patients: A Multicenter Nested Case-Control Study

tetano

Editor, Senior Moderator
BMC Med


. 2020 Jun 3;18(1):168.
doi: 10.1186/s12916-020-01633-7.
Lactate Dehydrogenase and Susceptibility to Deterioration of Mild COVID-19 Patients: A Multicenter Nested Case-Control Study


Jichan Shi[SUP] 1 [/SUP], Yang Li[SUP] 2 [/SUP], Xian Zhou[SUP] 2 [/SUP], Qiran Zhang[SUP] 2 [/SUP], Xinchun Ye[SUP] 1 [/SUP], Zhengxing Wu[SUP] 1 [/SUP], Xiangao Jiang[SUP] 1 [/SUP], Hongying Yu[SUP] 3 [/SUP], Lingyun Shao[SUP] 2 [/SUP], Jing-Wen Ai[SUP] 2 [/SUP], Haocheng Zhang[SUP] 2 [/SUP], Bin Xu[SUP] 2 [/SUP], Feng Sun[SUP] 4 [/SUP], Wenhong Zhang[SUP] 2 5 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) has infected more than 4 million people within 4 months. There is an urgent need to properly identify high-risk cases that are more likely to deteriorate even if they present mild diseases on admission.
Methods: A multicenter nested case-control study was conducted in four designated hospitals in China enrolling confirmed COVID-19 patients who were mild on admission. Baseline clinical characteristics were compared between patients with stable mild illness (stable mild group) and those who deteriorated from mild to severe illness (progression group).
Results: From Jan 17, 2020, to Feb 1, 2020, 85 confirmed COVID-19 patients were enrolled, including 16 in the progression group and 69 in the stable mild group. Compared to stable mild group (n = 69), patients in the progression group (n = 16) were more likely to be older, male, presented with dyspnea, with hypertension, and with higher levels of lactase dehydrogenase and c-reactive protein. In multivariate logistic regression analysis, advanced age (odds ratio [OR], 1.012; 95% confidence interval [CI], 1.020-1.166; P = 0.011) and the higher level of lactase dehydrogenase (OR, 1.012; 95% CI, 1.001-1.024; P = 0.038) were independently associated with exacerbation in mild COVID-19 patients.
Conclusion: Advanced age and high LDH level are independent risk factors for exacerbation in mild COVID-19 patients. Among the mild patients, clinicians should pay more attention to the elderly patients or those with high LDH levels.

Keywords: COVID-19; Lactate dehydrogenase; SARS-CoV-2; Severe pneumonia.
 
Back
Top Bottom